{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:14:54Z","timestamp":1786986894830,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.clnesp.2025.03.026","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T13:38:59Z","timestamp":1742305139000},"page":"660-664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Influence of high-fiber diet on ipilimumab-induced gastrointestinal toxicity in metastatic melanoma"],"prefix":"10.1016","volume":"67","author":[{"given":"Pawel","family":"Majenka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5430-1972","authenticated-orcid":false,"given":"Matthias","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Strobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"R\u00f6tzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Enk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7575-6230","authenticated-orcid":false,"given":"Jessica C.","family":"Hassel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.clnesp.2025.03.026_bib1","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.clnesp.2025.03.026_bib2","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S1470-2045(18)30700-9","article-title":"Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial","volume":"19","author":"Hodi","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clnesp.2025.03.026_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejca.2017.06.021","article-title":"Risk of treatment-related mortality in cancer patients treated with ipilimumab: a systematic review and meta-analysis","volume":"83","author":"Zhang","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clnesp.2025.03.026_bib4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ctrv.2017.05.003","article-title":"Combined immune checkpoint blockade (anti-PD-1\/anti-CTLA-4): evaluation and management of adverse drug reactions","volume":"57","author":"Hassel","year":"2017","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"10.1016\/j.clnesp.2025.03.026_bib5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1053\/j.seminoncol.2010.09.007","article-title":"The emerging toxicity profiles of anti-CTLA-4 antibodies across clinical indications","volume":"37","author":"Di Giacomo","year":"2010","journal-title":"Semin Oncol"},{"issue":"12","key":"10.1016\/j.clnesp.2025.03.026_bib6","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/jamaoncol.2018.3923","article-title":"Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"4","author":"Wang","year":"2018","journal-title":"JAMA Oncol"},{"issue":"suppl_4","key":"10.1016\/j.clnesp.2025.03.026_bib7","doi-asserted-by":"crossref","first-page":"iv119","DOI":"10.1093\/annonc\/mdx225","article-title":"Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Haanen","year":"2017","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.clnesp.2025.03.026_bib8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/jgh.12888","article-title":"Ipilimumab-induced toxicities and the gastroenterologist","volume":"30","author":"Cheng","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.clnesp.2025.03.026_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/CMR.0000000000000543","article-title":"Mycophenolate mofetil alongside high-dose corticosteroids: optimizing the management of combination immune checkpoint inhibitor-induced colitis","volume":"29","author":"Mir","year":"2019","journal-title":"Melanoma Res"},{"key":"10.1016\/j.clnesp.2025.03.026_bib10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejca.2017.09.019","article-title":"Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis","volume":"86","author":"Franklin","year":"2017","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.clnesp.2025.03.026_bib11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/bjc.2017.274","article-title":"Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers","volume":"117","author":"Hopkins","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clnesp.2025.03.026_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40425-015-0081-1","article-title":"Baseline circulating IL-17 predicts toxicity while TGF-\u03b21 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma","volume":"3","author":"Tarhini","year":"2015","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.clnesp.2025.03.026_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejca.2016.12.038","article-title":"Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity","volume":"75","author":"Gutzmer","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clnesp.2025.03.026_bib14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejca.2018.10.018","article-title":"Diet-dependent toxicity of ipilimumab in metastatic melanoma","volume":"106","author":"Majenka","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clnesp.2025.03.026_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1475-2891-9-36","article-title":"Relative validation of a food frequency questionnaire for national health and nutrition monitoring","volume":"9","author":"Haftenberger","year":"2010","journal-title":"Nutr J"},{"key":"10.1016\/j.clnesp.2025.03.026_bib16","series-title":"Ballaststoffe (Nahrungsfasern) [web source]","year":"2021"},{"issue":"5","key":"10.1016\/j.clnesp.2025.03.026_bib17","first-page":"e1","volume":"40","author":"Arends","year":"2015","journal-title":"Klinische Ern\u00e4hrung in der Onkologie"},{"issue":"8","key":"10.1016\/j.clnesp.2025.03.026_bib18","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ni.3754","article-title":"Nutrition, inflammation and cancer","volume":"18","author":"Zitvogel","year":"2017","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.clnesp.2025.03.026_bib19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.trecan.2021.02.005","article-title":"Targeting the gut microbiome to mitigate immunotherapy-induced colitis in cancer","volume":"7","author":"Chang","year":"2021","journal-title":"Trends Cancer"},{"issue":"5","key":"10.1016\/j.clnesp.2025.03.026_bib20","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.cell.2016.10.043","article-title":"A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility","volume":"167","author":"Desai","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.clnesp.2025.03.026_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00394-015-1068-x","article-title":"Preventive rather than therapeutic treatment with high fiber diet attenuates clinical and inflammatory markers of acute and chronic DSS-induced colitis in mice","volume":"56","author":"Silveira","year":"2017","journal-title":"Eur J Nutr"},{"issue":"12","key":"10.1016\/j.clnesp.2025.03.026_bib22","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1046\/j.1365-2036.1998.00432.x","article-title":"Treatment of ulcerative colitis with germinated barley foodstuff feeding: a pilot study","volume":"12","author":"Mitsuyama","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.clnesp.2025.03.026_bib23","first-page":"643","article-title":"Germinated barley foodstuff prolongs remission in patients with ulcerative colitis","volume":"13","author":"Hanai","year":"2004","journal-title":"Int J Mol Med"},{"issue":"2","key":"10.1016\/j.clnesp.2025.03.026_bib24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00054725-200303000-00005","article-title":"Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study","volume":"9","author":"Hallert","year":"2003","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10.1016\/j.clnesp.2025.03.026_bib25","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cgh.2020.05.026","article-title":"Low-fat, high-fiber diet reduces markers of inflammation and dysbiosis and improves quality of life in patients with ulcerative colitis","volume":"19","author":"Fritsch","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.clnesp.2025.03.026_bib26","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1038\/s41591-022-01965-2","article-title":"Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome","volume":"28","author":"Simpson","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.clnesp.2025.03.026_bib27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejca.2020.07.026","article-title":"Role of the gut microbiome for cancer patients receiving immunotherapy: dietary and treatment implications","volume":"138","author":"Lee","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clnesp.2025.03.026_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10391","article-title":"Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis","volume":"7","author":"Dubin","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.clnesp.2025.03.026_bib29","series-title":"Abstract 2838: the gut microbiome (GM) and immunotherapy response are influenced by host lifestyle factors","first-page":"2838","author":"Spencer","year":"2019"},{"issue":"6575","key":"10.1016\/j.clnesp.2025.03.026_bib30","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1126\/science.aaz7015","article-title":"Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response","volume":"374","author":"Spencer","year":"2021","journal-title":"Science"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725001172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725001172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T10:12:13Z","timestamp":1747217533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457725001172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":30,"alternative-id":["S2405457725001172"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.03.026","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of high-fiber diet on ipilimumab-induced gastrointestinal toxicity in metastatic melanoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.","name":"copyright","label":"Copyright"}]}}